Robert Burns
Stock Analyst at HC Wainwright & Co.
(1.22)
# 3,583
Out of 4,944 analysts
484
Total ratings
31.75%
Success rate
-13.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Maintains: Buy | $40 → $42 | $16.95 | +147.79% | 11 | Aug 12, 2025 | |
| EXEL Exelixis | Maintains: Buy | $53 → $46 | $37.95 | +21.21% | 10 | Aug 12, 2025 | |
| BDTX Black Diamond Therapeutics | Maintains: Buy | $12 → $10 | $2.54 | +293.70% | 14 | Aug 11, 2025 | |
| YMAB Y-mAbs Therapeutics | Downgrades: Neutral | $11 → $8.6 | $8.51 | +1.06% | 22 | Aug 6, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $22 → $21 | $11.56 | +81.74% | 13 | Aug 6, 2025 | |
| CRDF Cardiff Oncology | Maintains: Buy | $18 → $10 | $2.43 | +311.52% | 3 | Aug 6, 2025 | |
| ACET Adicet Bio | Assumes: Buy | $4 | $0.64 | +525.98% | 1 | Jul 23, 2025 | |
| REPL Replimune Group | Downgrades: Neutral | n/a | $5.25 | - | 18 | Jul 23, 2025 | |
| ELTX Elicio Therapeutics | Maintains: Buy | $10 → $13 | $9.40 | +38.30% | 8 | Jul 17, 2025 | |
| KPTI Karyopharm Therapeutics | Downgrades: Neutral | n/a | $4.06 | - | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $34 | $10.02 | +239.32% | 16 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $13 | $13.01 | -0.08% | 21 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $10.82 | +112.57% | 1 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $18.83 | +154.91% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $138 | $111.00 | +24.32% | 43 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.30 | +204.35% | 8 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $41 | $10.48 | +291.22% | 4 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $3.25 | +269.23% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $72 | $35.26 | +104.20% | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $9.52 | +131.09% | 24 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.84 | +496.66% | 16 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $1.79 | +67.60% | 14 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $6.76 | +92.31% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.94 | +172.11% | 21 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.98 | +151.26% | 3 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.47 | +36.05% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.44 | +247.22% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.03 | +676.70% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $2.00 | +1,600.00% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.32 | +331.03% | 14 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.56 | +220.51% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.35 | +377.61% | 21 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.46 | - | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $11.54 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.30 | +746.15% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $5.74 | +3,384.32% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $5.29 | +4,436.86% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.71 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $1.75 | +8,474.37% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $0.94 | +647.62% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $1.86 | +491.40% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $4.71 | +955,314.01% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $3.58 | +598.32% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $2.16 | +503.25% | 1 | Jan 7, 2021 |
ArriVent BioPharma
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $16.95
Upside: +147.79%
Exelixis
Aug 12, 2025
Maintains: Buy
Price Target: $53 → $46
Current: $37.95
Upside: +21.21%
Black Diamond Therapeutics
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.54
Upside: +293.70%
Y-mAbs Therapeutics
Aug 6, 2025
Downgrades: Neutral
Price Target: $11 → $8.6
Current: $8.51
Upside: +1.06%
Cogent Biosciences
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $21
Current: $11.56
Upside: +81.74%
Cardiff Oncology
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $2.43
Upside: +311.52%
Adicet Bio
Jul 23, 2025
Assumes: Buy
Price Target: $4
Current: $0.64
Upside: +525.98%
Replimune Group
Jul 23, 2025
Downgrades: Neutral
Price Target: n/a
Current: $5.25
Upside: -
Elicio Therapeutics
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $9.40
Upside: +38.30%
Karyopharm Therapeutics
Jul 16, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.06
Upside: -
Jul 14, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $10.02
Upside: +239.32%
Jul 3, 2025
Reiterates: Neutral
Price Target: $13
Current: $13.01
Upside: -0.08%
Jul 3, 2025
Initiates: Buy
Price Target: $23
Current: $10.82
Upside: +112.57%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $18.83
Upside: +154.91%
Jun 25, 2025
Reiterates: Buy
Price Target: $138
Current: $111.00
Upside: +24.32%
Jun 4, 2025
Reiterates: Buy
Price Target: $7
Current: $2.30
Upside: +204.35%
May 16, 2025
Maintains: Buy
Price Target: $44 → $41
Current: $10.48
Upside: +291.22%
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $3.25
Upside: +269.23%
May 14, 2025
Maintains: Buy
Price Target: $73 → $72
Current: $35.26
Upside: +104.20%
May 9, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $9.52
Upside: +131.09%
May 5, 2025
Reiterates: Buy
Price Target: $5
Current: $0.84
Upside: +496.66%
Apr 28, 2025
Maintains: Buy
Price Target: $9 → $3
Current: $1.79
Upside: +67.60%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $6.76
Upside: +92.31%
Mar 31, 2025
Reiterates: Buy
Price Target: $8
Current: $2.94
Upside: +172.11%
Mar 31, 2025
Reiterates: Buy
Price Target: $10
Current: $3.98
Upside: +151.26%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.47
Upside: +36.05%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.44
Upside: +247.22%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.03
Upside: +676.70%
Mar 18, 2025
Maintains: Buy
Price Target: $40 → $34
Current: $2.00
Upside: +1,600.00%
Mar 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.32
Upside: +331.03%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.56
Upside: +220.51%
Mar 7, 2025
Reiterates: Buy
Price Target: $16
Current: $3.35
Upside: +377.61%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.46
Upside: -
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $11.54
Upside: -
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.30
Upside: +746.15%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $5.74
Upside: +3,384.32%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $5.29
Upside: +4,436.86%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.71
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $1.75
Upside: +8,474.37%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $0.94
Upside: +647.62%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $1.86
Upside: +491.40%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $4.71
Upside: +955,314.01%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $3.58
Upside: +598.32%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $2.16
Upside: +503.25%